Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nutritional Risk Screening in Gynaecologic Oncology Surgery: Importance, Scoring Systems, Recommendations and Practical Applications.

Journal of clinical medicine·2026
Same author

Automated extraction of ESGO operative report fields from free-text surgical notes using large language models in advanced ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Antithrombotic Therapy in Percutaneous Atrial Structural Interventions.

Journal of cardiovascular development and disease·2026
Same author

Cardiology knowledge assessment of retrieval-augmented open versus proprietary large language models.

PLOS digital health·2026
Same author

Twelve-Month Outcomes Using Aflibercept 8 mg in Treatment-Naïve and Pretreated Diabetic Macular Edema: A Swiss Retina Research Network Report.

Ophthalmology science·2026
Same author

Prognostic and immunological significance of tryptophan metabolic enzymes across endometrial cancer molecular subtypes.

Gynecologic oncology·2025

Related Experiment Video

Updated: Jun 13, 2025

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
11:29

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

14.0K

Survival Dynamics in Advanced Ovarian Cancer: R2 Resection Versus No-Surgery Paths Explored.

Konstantinos Pitsikakis1, Diederick DeJong1, Konstantinos Kitsos-Kalyvianakis1

  • 1Department of Gynaecologic Oncology, ESGO Centre of Excellence for ovarian cancer surgery, St James's University Hospital, Leeds, UK.

Cancer Control : Journal of the Moffitt Cancer Center
|September 16, 2024
PubMed
Summary

For advanced epithelial ovarian cancer (EOC), R2 resection, leaving >1 cm of tumor, showed a survival benefit over no surgery. Both groups had poor prognoses, but R2 resection offered better progression-free and overall survival outcomes.

Keywords:
R2 resectioncytoreductionepithelial ovarian cancermachine learningnatural language processingprincipal component analysisprognosis estimationsurvival analysis

More Related Videos

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

10.8K
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

400

Related Experiment Videos

Last Updated: Jun 13, 2025

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
11:29

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

14.0K
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

10.8K
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

400

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gynecologic Oncology

Background:

  • Cytoreductive surgery is crucial for managing advanced epithelial ovarian cancer (EOC).
  • Suboptimal cytoreduction (R2 resection, >1 cm residual tumor) or no surgery presents challenges in patient management.
  • Comparing outcomes between R2 resection and no surgery is vital for treatment strategies.

Purpose of the Study:

  • To compare progression-free survival (PFS) and overall survival (OS) in advanced EOC patients with R2 resection versus no surgery.
  • To identify prognostic factors influencing survival in these patient groups.
  • To evaluate the utility of pre-operative CT reports in predicting residual disease.

Main Methods:

  • Retrospective analysis of 51 patients with R2 resection and 122 patients with no surgery (Jan 2015-Dec 2019).
  • Utilized Principal Component Analysis and Term Frequency-Inverse Document Frequency for data analysis and prediction.
  • Assessed PFS and OS as primary endpoints, with serous histology and performance status as independent predictors.

Main Results:

  • No significant difference in PFS between groups (14 vs 12 months), but OS was significantly better for R2 resection (26 vs 14 months, P=.001).
  • Age was the only statistically significant difference between groups (73 vs 67 years, P=.001).
  • Serous histology and performance status predicted PFS; serous histology predicted OS in no-surgery, while serous histology and chemotherapy predicted OS in R2 cohorts.

Conclusions:

  • Both R2 resection and no-surgery cohorts for advanced EOC have unfavorable prognoses.
  • R2 resection may offer a survival benefit compared to no surgery, even with suboptimal tumor clearance.
  • Adjuvant chemotherapy and serous histology are important prognostic factors in the R2 resection group.